Long-acting methylphenidate reduces collision rates of young adult drivers with attention-deficit/hyperactivity disorder

Journal of Clinical Psychopharmacology

Volumn 32, Issue 2, 2012, Pages 225-230

  Cox, Daniel J ^a   Davis, Margaret ^a   Mikami, Amori Yee ^b   Singh, Harsimran ^a   Merkel, Richard L ^a   Burket, Roger ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Activities of daily living; ADHD; Attention deficit hyperactivity disorder; Collisions; Daytrana; Driving; Medication; Methylphenidate

Indexed keywords

METHYLPHENIDATE;

ACCIDENT PREVENTION; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BLOOD PRESSURE; BODY WEIGHT; CLINICAL ARTICLE; CONNERS ADULT ADHD RATING SCALE; CONTROLLED STUDY; COX ASSESSMENT OF RISKY DRIVING SCALE; CROSSOVER PROCEDURE; DRIVER; DRIVING ABILITY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; FEMALE; HEART RATE; HUMAN; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SELF REPORT; SKIN MANIFESTATION; TRAFFIC ACCIDENT; TREATMENT DURATION; VIDEORECORDING;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTOMOBILE DRIVING; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MALE; METHYLPHENIDATE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; RISK-TAKING; TREATMENT OUTCOME; VIDEO RECORDING; YOUNG ADULT;

EID: 84857825292     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182496dc5     Document Type: Article

References (17)

1. Barkley RA. Driving impairments in teens and adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004;27:233-260. (Pubitemid 38452766)
2. Barkley RA, Cox D. A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance. J Safety Res. 2007;38:113-128. (Pubitemid 46321543)
3. Jerome L, Habinski L, Segal A. Attention-deficit/hyperactivity disorder (ADHD) and driving risk: a review of the literature and a methodological critique. Curr Psychiatry Rep. 2006;8:416-426. (Pubitemid 44515395)
4. Cox DJ, Taylor-Davis M. Attention deficit/hyperactivity disorder (ADHD) and driving safety. In: Verster JE, Pandi-Perumal SR, Ramaekers JG, et al, eds. Drugs, Driving and Traffic Safety. Basel, Switzerland: Birkhii user Verlag; 2009;315-330.
5. Cox DJ, Cox BS, Cox J. Self reported incidences of moving vehicle collisions and citations among drivers with attention deficit/hyperactivity disorder (ADHD), a cross-sectional survey across the lifespan. Am J Psychiatry. 2011;168(3):329-330.
6. Kay GG, Michaels MA, Pakull B. Simulated driving changes in young adults with ADHD receiving mixed amphetamine salts extended release and atomoxetine. J Atten Disord. 2009;12:316-329.
7. Cox DJ, Moore M, Burket R, et al. Rebound effects with long acting amphetamine or methylphenidate stimulant medication preparations among adolescent male drivers with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol. 2008;18:1-10. (Pubitemid 351311239)
8. Williams AF. Teenage drivers: patterns of risk. J Safety Res. 2003;34:5-15.
9. Erhardt D, Epstein JN, Conners CK, et al. Self-ratings of ADHD symptoms in adults: II. Reliability, validity, and diagnostic sensitivity. J Atten Disord. 1999;3:153-158.
10. Cox BS, Cox DJ. Risk taking while driving: a scale to measure risk taking and its relationship to driving mishaps. In: Poster Session Presented at: 162nd Annual Meeting of the American. Boston, MA: Psychiatric Association; 2009.
11. Barkley RA. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 3rd ed. New York, NY: Guilford Press; 2005.
12. AARDEX Group. Available at: http://www.aardexgroup.com/aardex-index.php? group=aardex&id=85. Accessed June 29, 2009.
13. Dingus TA, Klauer SG, Neale VL, et al. The 100-Car Naturalistic Driving Study. Phase II. Results of the 100-Car Field Experiment DOT HS 810 593. Washington, DC: US DOT National Highway Traffic Safety Administration; 2006. Available at: http://www.nhtsa.gov/DOT/ NHTSA/NRD/Multimedia/PDFs/ Crash%20Avoidance/2002/ 100CarPhase1Report.pdf. Accessed June 29, 2009.
14. McGehee D, Raby M, Carney D, et al. Extending parental mentoring using an event-triggered video intervention in rural teen drivers. J Safety Res. 2007;38:215-227. (Pubitemid 46661950)
15. Cox DJ, Mikami A, Cox BS, et al. Impact of long acting methylphenidate on routine driving of adolescents with attention-deficit/hyperactivity disorder (ADHD): two case reports. Arch Pediatr Adolesc Med. 2008;162:793-794.
16. Findling RL, Katic A, Rubin R, et al. A 6-month, open-label, extension study of the tolerability and effectiveness of the methylphenidate transdermal system in adolescents diagnosed with attention-deficit/ hyperactivity disorder. J Clin Psychoparmacol. 2010;20:365-375.
17. Findling RL, Turnbow J, Burnside J, et al. A randomized, double-blind, multicenter, parallel-group, placebo-controlled, dose-optimization study of the methylphenidate transdermal system for the treatment of ADHD in adolescents. CNS Spectr. 2010;15:419-430.